Wild-type BRCA1, but not Mutated BRCA1, Regulates the Expression of the Nuclear Form of β-catenin

作者: Huchun Li , Masayuki Sekine , Nadine Tung , Hava Karsenty Avraham

DOI: 10.1158/1541-7786.MCR-09-0403

关键词:

摘要: BRCA1 is an essential caretaker protein in the surveillance of DNA damage, mutated approximately 50% all hereditary breast cancer cases, and its expression frequently decreased sporadic cancer. beta-Catenin a multifunctional that forms adhesion complex with E-cadherins, alpha-catenin, actin, plays central role Wnt signaling through nuclear translocation activation beta-catenin-responsive genes. Although significant progress has been made understanding Wnt/beta-catenin cascades, it not known whether there link between beta-catenin BRCA1. We observed active form (also as ABC, Ser37/Thr41-nonphosphorylated beta-catenin, dephosphorylated beta-catenin) was lower or absent nucleus most familial tissues (17 cases) compared (14 samples) normal tissues. Wild-type-BRCA1, but BRCA1, interacted increased levels vitro. Furthermore, H(2)O(2) induced interaction The downregulated upon exposure to BRCA1-deficient HCC1937 cells, whereas reconstitution WT-BRCA1 cells inhibited this downregulation. This study provides evidence novel loss leads impaired which may contribute pathogenesis

参考文章(59)
Sarah Hatsell, Tracey Rowlands, Minoti Hiremath, Pamela Cowin, β-catenin and tcfs in mammary development and cancer Journal of Mammary Gland Biology and Neoplasia. ,vol. 8, pp. 145- 158 ,(2003) , 10.1023/A:1025944723047
KB Pedersen, JM Nesland, Ø Fodstad, GM Maelandsmo, None, Expression of S100A4, E-cadherin, α- and β-catenin in breast cancer biopsies British Journal of Cancer. ,vol. 87, pp. 1281- 1286 ,(2002) , 10.1038/SJ.BJC.6600624
Serge Y Fuchs, The role of ubiquitin-proteasome pathway in oncogenic signaling. Cancer Biology & Therapy. ,vol. 1, pp. 337- ,(2002)
Sylvia De Brakeleer, Marika Bogdani, Jacques De Grève, Julie Decock, Erica Sermijn, Maryse Bonduelle, Guido Goelen, Erik Teugels, Loss of nuclear BRCA1 protein staining in normal tissue cells derived from BRCA1 and BRCA2 mutation carriers. Mutation Research. ,vol. 619, pp. 104- 112 ,(2007) , 10.1016/J.MRFMMM.2007.02.031
Ko Sato, Ryosuke Hayami, Wenwen Wu, Toru Nishikawa, Hiroyuki Nishikawa, Yoshiko Okuda, Haruki Ogata, Mamoru Fukuda, Tomohiko Ohta, Nucleophosmin/B23 is a candidate substrate for the BRCA1-BARD1 ubiquitin ligase. Journal of Biological Chemistry. ,vol. 279, pp. 30919- 30922 ,(2004) , 10.1074/JBC.C400169200
P. S. Brzovic, J. R. Keeffe, H. Nishikawa, K. Miyamoto, D. Fox, M. Fukuda, T. Ohta, R. Klevit, Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 100, pp. 5646- 5651 ,(2003) , 10.1073/PNAS.0836054100
B Rigas, Y Sun, Induction of oxidative stress as a mechanism of action of chemopreventive agents against cancer British Journal of Cancer. ,vol. 98, pp. 1157- 1160 ,(2008) , 10.1038/SJ.BJC.6604225
Sharon Amit, Yinon Ben-Neriah, NF-κB activation in cancer: a challenge for ubiquitination- and proteasome-based therapeutic approach Seminars in Cancer Biology. ,vol. 13, pp. 15- 28 ,(2003) , 10.1016/S1044-579X(02)00096-2
Daniel A Bochar, Lai Wang, Hideo Beniya, Alexander Kinev, Yutong Xue, William S Lane, Weidong Wang, Fatah Kashanchi, Ramin Shiekhattar, BRCA1 Is Associated with a Human SWI/SNF-Related Complex: Linking Chromatin Remodeling to Breast Cancer Cell. ,vol. 102, pp. 257- 265 ,(2000) , 10.1016/S0092-8674(00)00030-1